1  insulin depot, estimated to be 450 units of regular insulin.

2 eceived SC insulin aspart and 59 received IV regular insulin.

3 erapy, using short-acting insulin analogs or regular insulin.

4 nitially stabilized with twice-daily NPH and regular insulin.

5 lamp period infusions were peripheral venous regular insulin (0.1 nmol kg(-1) h(-1) [control], n = 6)

6  for MK-2640 (threefold) was observed versus regular insulin (1.3-fold).

7 n and lipolysis were like that attained with regular insulin, albeit with a distinctly shallower dose

8 mic efficacy slightly less than subcutaneous regular insulin and increased patient acceptability.

9    Subjects received 0.08 U/kg body wt human regular insulin as an intravenous bolus to produce moder

10 ere performed after intravenous injection of regular insulin (group I) or oral glucose administration

11 ous intravenous insulin solutions (100 units regular insulin in 100 mL: normal saline) beginning at t

12 -acting insulin analogues are preferred over regular insulin in patients with type 1 DM since they im

13 est that SC insulin aspart is dominant vs IV regular insulin in the management of mild uncomplicated

14            Subcutaneous insulin aspart vs IV regular insulin infusion.

15            Five normal men were infused with regular insulin to maintain levels comparable to that in

16  [95% CI, -32.41 to -2.04]; P = .03) than IV regular insulin when controlling for age and sex.